Dutch private equity firm Holland Capital is set to purchase 50% of the shares of youth clinic and treatment centre Yes We Can. The current shareholders will remain in place.
What can you do with AI and big data today and what will be possible within three years? Why has adoption been slower than you might have expected? And what sort of role should health care providers look to play? HBI gets an expert view from digital, technology and business strategy expert Klaus Boehncke, partner at L.E.K. Consulting, who is chairing the Best Practice Workshop: Delivering Digital Excellence: A Framework for Success at HBI 2020 in two weeks.
UK Addiction Treatment claims 97% occupancy within a week of opening its latest facility. But would you invest in a business run by addicts for addicts? Or whose majority investor, Global Group, has recently seen its founder, Greg Lindbergh, jailed for bribing a US official? We talk to UKAT CEO, Eytan Alexander.
Analyst forecasts suggest that healthcare sector valuations have been largely unaffected by the crisis, with EMEA hospitals and medtech stocks now being more expensive than before the Covid outbreak, both on an EBITDA and PE multiples basis.
Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.
This week we plot medical staff spending in France against total hospitalisation rates and explore how the numbers paint a picture of national sectors. What treatments cost businesses and payors the most in staff resources? Where are inpatient admissions the highest?
The American press is reporting that US-based private equity giant KKR is ‘nearing a deal’ to buy addiction treatment specialists Acadia Healthcare. The purchase would bring one of America's largest PE giants into the UK healthcare industry for the first time. How are KKR's international healthcare investments fairing?
The American press is reporting that global private equity giant KKR is 'nearing a deal' to buy addiction treatment specialists Acadia Healthcare. As we previously reported, rumours of sale continue to surround its UK-subsidiary Priory Group.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
